Posted by Lou Pilder on February 28, 2012, at 12:36:05
In reply to Lou's reply-agranulocytosis-cases » Solstice, posted by Lou Pilder on February 28, 2012, at 12:27:57
> > Lou -
> >
> > I guess you are aware that your link's Clinical Investigation reiterates what Scott said - that since Saphris is not activating the 5-HT2b receptors, it is not implicated in agranulocytosis.
> >
> > Solstice
> >
> >
> >
> > > > > Scott,
> > > > > Saphris is a newer drug so the reports are not many yet as a drug like Prozac. Neutropenia is more eventfull than agranulocytosis, but as more time runs there could be more reports of that event.
> > > > > Now what is the chemical concerning receptors are the matabolites. This could change things a bit...
> > > > > Now here is a report that I think could be of help here. I have the report on deaths with saphris in the trials and will put that together later.
> > > > > Lou
> > > > > http://circ.ahjournals.org/content/1022/23/2836.full
> > > > corrected:
> > > > http://circ.ahjournals.org/content/102/23/2836.full
> > >
> > > correction:
> > > http://circ.ahajournals.org/content/102/23/2836.full
> >
> > Solstice,
> In regards to accepting or not as to if one taking Saphris could get agranulocytosis or not, here is a link tthat could be helpful to accepting or not that ine could or could not get agranuloocytosis. Then we could go from there.
> Lou
> http://doublecheckmd.com/EffectsDetail.do?dname=167374&eid=3093
>
> correction:
http://doublecheckmd.com/EffectsDetail.do?dname=Saphris&sid=167374&eid=3093
poster:Lou Pilder
thread:1011122
URL: http://www.dr-bob.org/babble/20120221/msgs/1011913.html